Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2015 ∙ Malerba, V. Costantino, C. Napoli, G. Marchese, V. Casuccio, A. Tabacchi, G. Vitale, F.
Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review
Europe Adolescents Adults Older adults Parents/caregivers Meningococcal disease Pneumococcal disease Coverage Acceptance
Rating:
Not applicable
2015 ∙ Vlachopoulos, C. V. Terentes-Printzios, D. G. Aznaouridis, K. A. Pietri, P. G. Stefanadis, C. I.
Association between pneumococcal vaccination and cardiovascular outcomes: A systematic review and meta-analysis of cohort studies
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2015 ∙ Wu, D. B. C. Chaiyakunapruk, N. Chong, H. Y. Beutels, P.
Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006-2014)
All age groups Pneumococcal disease Economic aspects Administration Coverage
Rating:
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.
Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review
All age groups Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2015 ∙ Ren, S. Newby, D. Li, S. C. Walkom, E. Miller, P. Hure, A. Attia, J.
Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2015 ∙ De Waure, Chiara Specchia, Maria Lucia Capizzi, Silvio Aljicevic, Mufida Dujovic, Milos Malaj, Admir Ricciardi, Walter
Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies
Newborn Children Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2015 ∙ Bonner, K. Welch, E. Elder, K. Cohn, J.
Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review
Newborn Children Low and Middle Income Countries Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2015 ∙ Chaithongwongwatthana, S. Yamasmit, W. Limpongsanurak, S. Lumbiganon, P. Tolosa, J. E.
Pneumococcal vaccination during pregnancy for preventing infant infection
Pregnant women Pneumococcal disease Efficacy/effectiveness Safety
Rating:
High
2015 ∙ Alqahtani, A. S. Rashid, H. Heywood, A. E.
Vaccinations against respiratory tract infections at Hajj
All age groups Influenza Pneumococcal disease Diphtheria Tuberculosis Efficacy/effectiveness Coverage
Rating:
Not applicable
2015 ∙ Johansen, H. K. Gotzsche, P. C.
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
All age groups Pneumococcal disease Efficacy/effectiveness Safety Administration
Rating:
High
Loading...